2 unchanged sentences
In accordance with the disclosure requirements set forth in Item 408(a) of Regulation S-K, the following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act), director, or entity controlled by such officer or
−Removed: director who adopted a contract, instruction, or written plan for the sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) during the quarterly period ended March 31, 2024:
+Added: director who adopted or terminated a contract, instruction, or written plan for the sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) during the quarterly period ended June 30, 2024:
Name Title Action Taken Date of Action Duration of Trading Arrangement Aggregate Number of Securities to be Sold
−Removed: Jonathan Burth Chief Operating Officer Adoption March 15, 2024 June 14, 2024 to July 31, 2025 Up to 100,000 shares of Common Stock issuable upon exercise of fully vested stock options and up to 40,000 shares of Common Stock
−Removed: Jane Prior Chief Marketing Officer Adoption March 15, 2024 June 14, 2024 to February 3, 2025 Up to 50,000 shares of Common Stock upon exercise of fully vested stock options
−Removed: Charles van Es Chief Sales Officer Adoption March 15, 2024 June 14, 2024 to January 31, 2025 Up to 39,675 shares of Common Stock upon exercise of fully vested stock options
+Added: The Michael Kirban Revocable Trust A trust controlled by Michael Kirban (Co-Founder, Executive Chairman and Chairman of the Board) Termination May 17, 2024 September 14, 2023 to September 13, 2024 Up to 240,000 shares of Common Stock
+Added: The Ira Liran 2012 Family Trust A trust controlled by Ira Liran Adoption June 14, 2024 September 14, 2024 to September 18, 2025 Up to 250,000 shares of Common Stock
Other than as disclosed above, no other officer, director or entity controlled by such officer or director adopted , modified or terminated a contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement.
13 unchanged sentences
8-K 001-40950 10.2 10/25/21
−Removed: 4.4 F orm of Indenture
−Removed: 333-271583 4.4 5/2/23
−Removed: S econd Amendment to Amended and Restated Employment Agreement, by and between The Vita Coco Company, Inc., and Michael Kirban, dated March 4, 2024
+Added: 4.4 Form of Indenture
333-271583 4.4 5/2/23
−Removed: M anufacturing and Purchasing Agreement, by and among Century Pac ific Food, Inc.
−Removed: and All Market Singapore Pte .
−Removed: Ltd., dated as of March 8, 2024
+Added: Co- Manufacturing and Purchasing Agreement, by and among Axelum Resources Corp.
+Added: and All Mar ket Singapore P te.
+Added: d ated as of April 18, 2024
31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).
19 unchanged sentences
THE VITA COCO COMPANY, INC.
+Added: August 1, 2024
/s/ Martin Roper
1 unchanged sentence
(Principal Executive Officer)
+Added: August 1, 2024
/s/ Corey Baker
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.